Structural Formula For Bicalutimide (89c24844 4d2a 4ec6 Bc28 Adce7b82d0c0 01)
Bicalutamide
Product Images NDC 54868-6133
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 54868-6133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (The Kaplan-Meier Probability of Death for Both Antiandrogen Treatment Groups.)
Figure 2 (Kaplan-Meier Curve for Time to Progression for Both Antiandrogen Treatment Groups.)
This appears to be a table or chart format rather than a full description. As a result, it is difficult to provide a useful description with the given text. The text mentions different treatments such as Giattanice plus LHRH-A and Flutamide plus LHRH-A, as well as a measure of "proportion not progressing" and "days to progression." Without an understanding of the context and purpose of this chart or table, further description is not available.*
Image Of 50 mg Label (Package Label)
This is a label from a medication package of Bicalutahide 501g, distributed by Physicians Total Care, with NDC number 54868-6133-0. The LOT number is 6000 with an expiration date of 01/60.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
